Compare NEON & BCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NEON | BCTX |
|---|---|---|
| Founded | 1997 | 2014 |
| Country | Sweden | Canada |
| Employees | N/A | 4 |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 27.5M | 26.6M |
| IPO Year | 1994 | 2025 |
| Metric | NEON | BCTX |
|---|---|---|
| Price | $0.89 | $3.50 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $6.00 | ★ $40.00 |
| AVG Volume (30 Days) | 104.9K | ★ 127.0K |
| Earning Date | 05-13-2026 | 06-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 37.88 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $3,108,000.00 | N/A |
| Revenue This Year | $72.74 | N/A |
| Revenue Next Year | $28.94 | $380.95 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.72 | $0.63 |
| 52 Week High | $26.95 | $14.68 |
| Indicator | NEON | BCTX |
|---|---|---|
| Relative Strength Index (RSI) | 52.40 | 49.70 |
| Support Level | $0.73 | $2.98 |
| Resistance Level | $1.05 | $4.51 |
| Average True Range (ATR) | 0.07 | 0.26 |
| MACD | 0.03 | -0.04 |
| Stochastic Oscillator | 82.26 | 34.62 |
Neonode Inc provides software solutions for machine perception that feature machine learning algorithms to detect and track persons and objects in video streams from cameras and other types of imagers. Its machine perception solutions are based on the MultiSensing technology platform. The company also offers optical sensing solutions for contactless touch and gesture sensing. It markets and sells its solutions mainly to customers in the automotive sector, along with other markets such as office equipment, industrial automation, medical, military, and avionics. Geographically, the company operates in Japan, South Korea, Germany, Sweden, China, and other regions, with a majority of its revenue generated from Japan.
BriaCell Therapeutics Corp is a clinical-stage biotechnology company focused on developing immunotherapies for cancer treatment, particularly breast cancer. The company's targeted immunotherapy program, Bria-IMT, is a targeted cell-based immunotherapy in end-stage clinical trials aiming to improve outcomes for patients with breast cancer. BriaCell also develops Bria-OTS, personalized off-the-shelf immunotherapies for breast and prostate cancer. BriaCell is involved in clinical collaborations to explore combination therapies for enhanced cancer treatment options.